Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.9650 (1.3%) ($15.9650 - $15.9650) on Tue. Jun. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.47% (three month average) | RSI | 77 | Latest Price | $15.9650(1.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) IWO(37%) ARKK(36%) ARKG(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.735% in a week (0% probabilities). VIXM(-23%) UUP(-14%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.735% (StdDev 5.47%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $14.67(8.83%) | 10 Day Moving Average | $14.35(11.25%) | 20 Day Moving Average | $13.4(19.14%) | To recent high | 0% | To recent low | 68.1% | Market Cap | $2.817b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |